Valion Bio, Inc. (VBIO): Cost of Revenue
$778.0K
Year ended 2024-12-31
-15.6%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $778.0K | -12.5% | 2025-03-21, From 2024-01-01 |
| 2023-12-31 | $889.0K | -42.3% | 2025-03-21, From 2023-01-01 |
| 2022-12-31 | $1.54M | +19.0% | 2024-03-25, From 2022-01-01 |
| 2021-12-31 | $1.29M | n/a | 2023-03-31, From 2021-01-01 |